BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37918207)

  • 1. A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers.
    Dai Y; Li H; Wu Q; Wang J; Wang K; Fei S; Pei B; Song L; Chen G; Ma Y; Xia C; Xiong S; Zheng M; Xue Y; Zhao G; Xu H
    Neoplasia; 2023 Dec; 46():100941. PubMed ID: 37918207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying potential DNA methylation markers for the detection of esophageal cancer in plasma.
    Pei B; Zhao G; Geng Z; Wang Y; Wang M; Wang X; Xiong S; Zheng M
    Front Genet; 2023; 14():1222617. PubMed ID: 37867599
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-free DNA methylation profiles enable early detection of colorectal and gastric cancer.
    Lei X; Zhou D; Wen Y; Sha W; Ma J; Tu X; Zhai K; Li C; Wang H; Tao J; Chen Z; Ruan W; Fan JB; Wang B; Cui C
    Am J Cancer Res; 2024; 14(2):744-761. PubMed ID: 38455396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients.
    Zheng Y; Zhang Y; Huang X; Chen L
    Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
    Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
    Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
    Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
    Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cell-free DNA methylation-based blood test for colorectal cancer screening in high-risk population: a prospective cohort study.
    Zhao F; Bai P; Xu J; Li Z; Muhammad S; Li D; Zhang Z; Gao Y; Liu Q
    Mol Cancer; 2023 Sep; 22(1):157. PubMed ID: 37770864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancer.
    Li D; Zhang L; Fu J; Huang H; Liu Y; Zhu L; Sun H; Sun S; Zhang D; Tian T; Wang F; Hu F; Peng X; Li G; Zhao L; Zheng T; Wang X; Cui B; Zhao Y
    Clin Epigenetics; 2022 Aug; 14(1):102. PubMed ID: 35974349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection.
    Fang Q; Yuan Z; Hu H; Zhang W; Wang G; Wang X
    Clin Epigenetics; 2023 Jul; 15(1):119. PubMed ID: 37501075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
    Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
    J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in Colorectal Cancer.
    Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma.
    Qin Y; Wu CW; Taylor WR; Sawas T; Burger KN; Mahoney DW; Sun Z; Yab TC; Lidgard GP; Allawi HT; Buttar NS; Smyrk TC; Iyer PG; Katzka DA; Ahlquist DA; Kisiel JB
    Clin Cancer Res; 2019 Dec; 25(24):7396-7404. PubMed ID: 31527170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
    Ben-Ami R; Wang QL; Zhang J; Supplee JG; Fahrmann JF; Lehmann-Werman R; Brais LK; Nowak J; Yuan C; Loftus M; Babic A; Irajizad E; Davidi T; Zick A; Hubert A; Neiman D; Piyanzin S; Gal-Rosenberg O; Horn A; Shemer R; Glaser B; Boos N; Jajoo K; Lee L; Clancy TE; Rubinson DA; Ng K; Chabot JA; Kastrinos F; Kluger M; Aguirre AJ; Jänne PA; Bardeesy N; Stanger B; O'Hara MH; Till J; Maitra A; Carpenter EL; Bullock AJ; Genkinger J; Hanash SM; Paweletz CP; Dor Y; Wolpin BM
    Gut; 2024 Mar; 73(4):639-648. PubMed ID: 38123998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay.
    Zhang Y; Wu Q; Xu L; Wang H; Liu X; Li S; Hu T; Liu Y; Peng Q; Chen Z; Wu X; Fan JB
    Clin Epigenetics; 2021 Apr; 13(1):90. PubMed ID: 33892797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-Specific Hypermethylation of SST 1stExon as a Biomarker for Predicting the Risk of Gastrointestinal Tract Cancers.
    Dai X; Sun X; Wu Y; Lv Z; Yu Z; Yuan Y; Sun L
    Dis Markers; 2022; 2022():4570290. PubMed ID: 35242243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
    Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
    PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
    Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y
    BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.